Table 6.
Variable |
n |
Emax | Emean | Eratio | SD | ||||||||
Mean ± SD | β coefficient | p | Mean ± SD | β coefficient | p | Mean ± SD | β coefficient | p | Mean ± SD | β coefficient | p | ||
Histologic grade | |||||||||||||
1 | 5 | 235.44 ± 44.18 | 171.36 ± 36.73 | 10.78 ± 6.73 | 34.24 ± 8.36 | ||||||||
2 | 9 | 201.8 ± 88.92 | –33.64 ± 36.05 | 0.361 | 150.72 ± 59.23 | –20.64 ± 26.7 | 0.448 | 8.39 ± 6.54 | –2.39 ± 6.85 | 0.730 | 38.64 ± 38.97 | 4.4 ± 14.38 | 0.762 |
3 | 10 | 233.42 ± 43.06 | –2.02 ± 35.41 | 0.955 | 185.13 ± 40.34 | 13.77 ± 26.22 | 0.605 | 18.78 ± 17.15 | 8 ± 6.73 | 0.248 | 29.08 ± 13.07 | –5.16 ± 14.12 | 0.719 |
Lymph node status | |||||||||||||
Negative | 17 | 221.94 ± 63.67 | 173.15 ± 48.83 | 11.23 ± 9.01 | 27.09 ± 13.02 | ||||||||
Positive | 7 | 222.09 ± 69.25 | 0.14 ± 29.3 | 0.996 | 160.14 ± 49.59 | -13.01 ± 22.02 | 0.561 | 18.05 ± 19.1 | 6.82 ± 5.65 | 0.241 | 49.9 ± 38.96 | 22.81 ± 10.41 | 0.039 |
LVI | |||||||||||||
Negative | 20 | 217.53 ± 67.03 | 173.33 ± 51.78 | 12.26 ± 8.67 | 26.74 ± 16.96 | ||||||||
Positive | 4 | 244.25 ± 44.29 | 26.72 ± 35.27 | 0.457 | 149.5 ± 17.42 | -23.83 ± 26.59 | 0.380 | 18.04 ± 26.95 | 5.78 ± 7.01 | 0.419 | 68.78 ± 31.85 | 42.04 ± 10.77 | 0.001 |
Pathologic type | |||||||||||||
IDC | 21 | 230.07 ± 55 | 40.87 ± 56.29 | 0.476 | 174.43 ± 42.02 | 23.93 ± 43.01 | 0.584 | 14.2 ± 13.28 | 7.1 ± 13.59 | 0.607 | 34.66 ± 25.97 | 3.26 ± 26.58 13.1 ± 36.73 -25.4 ± 36.73 | 0.904 |
ILC | 1 | 256.70 | 67.5 ± 77.78 | 0.396 | 208.20 | 57.7 ± 59.43 | 0.343 | 9.79 | 2.69 ± 18.78 | 0.888 | 44.50 | 13.1 ± 36.73 | 0.725 |
DCIS | 1 | 50.30 | –138.9 ± 77.78 | 0.089 | 42.80 | –107.7 ± 59.43 | 0.085 | 2.13 | –4.97 ± 18.78 | 0.794 | 6.00 | –25.4 ± 36.73 | 0.497 |
Etc | 1 | 189.20 | 150.50 | 31.0 | 31.40 | ||||||||
ER | |||||||||||||
Negative | 6 | 210.25 ± 22.01 | 166.35 ± 21.43 | 8.26 ± 4.74 | 24.55 ± 14.11 | ||||||||
Positive | 18 | 225.89 ± 72.8 | 15.64 ± 30.57 | 0.614 | 170.36 ± 54.97 | 4.01 ± 23.28 | 0.865 | 14.87 ± 14.16 | 6.61 ± 5.96 | 0.280 | 36.81 ± 27.36 | 12.26 ± 11.77 | 0.309 |
PR | |||||||||||||
Negative | 6 | 219.08 ± 41.61 | 180.03 ± 41.42 | 8.94 ± 4.46 | 22.92 ± 10.97 | ||||||||
Positive | 18 | 222.95 ± 70.67 | 3.87 ± 30.74 | 0.901 | 165.8 ± 51.02 | –14.23 ± 23.1 | 0.544 | 14.64 ± 14.29 | 5.7 ± 6.01 | 0.353 | 37.35 ± 27.5 | 14.43 ± 11.66 | 0.229 |
HER2 | |||||||||||||
Negative | 16 | 224.49 ± 64.9 | 165.4 ± 47.11 | 11.89 ± 13.55 | 34.01 ± 23.99 | ||||||||
Positive | 8 | 216.96 ± 65.62 | –7.53 ± 28.2 | 0.792 | 177.28 ± 53.04 | 11.88 ± 21.25 | 0.582 | 15.88 ± 11.2 | 4 ± 5.56 | 0.480 | 33.2 ± 28.69 | –0.81 ± 11.08 | 0.942 |
Ki67 | |||||||||||||
<14 % | 8 | 244.1 ± 70.81 | 168.74 ± 46.63 | 11.64 ± 7.1 | 42.29 ± 30.23 | ||||||||
≥14 % | 14 | 222.93 ± 43.66 | –21.17 ± 24.25 | 0.393 | 179.27 ± 40.26 | 10.53 ± 18.88 | 0.583 | 15.38 ± 15.48 | 3.74 ± 5.84 | 0.529 | 31.63 ± 22.3 | –10.66 ± 11.24 | 0.354 |